Conjugated linoleic acid alters global gene expression in human intestinal-like Caco-2 cells in an isomer-specific manner

Journal of Nutrition

Volumn 137, Issue 11, 2007, Pages 2359-2365

  Murphy, Eileen F ^a   Hooiveld, Guido J ^b   Muller, Michael ^b   Calogero, Raffaele A ^c   Cashman, Kevin D ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID;

ARTICLE; CALCIUM TRANSPORT; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DNA METABOLISM; DNA MICROARRAY; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; STATISTICAL SIGNIFICANCE;

EID: 35848965462     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.11.2359     Document Type: Article

References (54)

1. Parodi PW. Distribution of isomeric octadecenoic fatty acids in milk fat. J Dairy Sci. 1976;59:1870-3.
2. Gaullier JM, Berven G, Blankson H, Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids. 2002;37:1019-25.
3. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001;40:283-98.
4. Black IL, Roche HM, Gibney MJ. Chronic but not acute treatment with conjugated linoleic acid (CLA) isomers (trans-10, cis-12 CLA and cis-9, trans-11 CLA) affects lipid metabolism in Caco-2 cells. J Nutr. 2002;132:2167-73.
5. Kim EJ, Holthuizen PE, Park HS, Ha YL, Jung KC, Park JH. Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth. Am J Physiol Gastrointest Liver Physiol. 2002;283:G357-67.
6. Jewell C, Cashman KD. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells. Br J Nutr. 2003;89:639-47.
7. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999;34:235-41.
8. Murphy EF, Jewell C, Hooiveld GJ, Muller M, Cashman KD. Conjugated linoleic acid enhances transepithelial calcium transport in human intestinal-like Caco-2 cells: an insight into molecular changes. Prostaglandins Leukot Essent Fatty Acids. 2006;74:295-301.
9. Wahle KW, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res. 2004;43:553-87.
10. Rudel LL. Atherosclerosis and conjugated linoleic acid. Br J Nutr. 1999;81:177-9.
11. Parodi PW. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci. 1999;82:1339-49.
12. MacDonald HB. Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr. 2000;19:S111-8.
13. Belury MA. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr. 2002;132:2995-8.
14. Miller A, Stanton C, Devery R. Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Res. 2002;22:3879-87.
15. Lim-do Y, Tyner AL, Park JB, Lee JY, Choi YH, Park JH. Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J Cell Physiol. 2005;205:107-13.
16. Kim EJ, Jun JG, Park HS, Kim SM, Ha YL, Park JH. Conjugated linoleic acid (CLA) inhibits growth of Caco-2 colon cancer cells: possible mediation by oleamide. Anticancer Res. 2002;22:2193-7.
17. Cho HJ, Lee HS, Chung CK, Kang YH, Ha YL, Park HS, Park JH. trans-10, cis-12 conjugated linoleic acid reduces insulin-like growth factor-II secretion in HT-29 human colon cancer cells. J Med Food. 2003;6:193-9.
18. Cho HJ, Kim WK, Jung JI, Kim EJ, Lim SS, Kwon DY, Park JH. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol. 2005;11:5142-50.
19. Cho HJ, Kim EJ, Lim SS, Kim MK, Sung MK, Kim JS, Park JH. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. J Nutr. 2006;136:893-8.
20. Jewell C, Cusack S, Cashman KD. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids. 2005;72:163-71.
21. Fleet JC, Wood RJ. Specific 1,25(OH)2D3-mediated regulation of transcellular calcium transport in Caco-2 cells. Am J Physiol. 1999;276:G958-64.
22. House RL, Cassady JP, Eisen EJ, Eling TE, Collins JB, Grissom SF, Odle J. Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol Genomics. 2005;21:351-61.
23. Kelly O, Cashman KD. The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats. Prostaglandins Leukot Essent Fatty Acids. 2004;71:295-301.
24. Kelly O, Cusack S, Jewell C, Cashman KD. The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats. Br J Nutr. 2003;90:743-50.
25. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4,5-f] quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis. 1995;16:3037-43.
26. Park HS, Cho HY, Ha YL, Park JH. Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. J Nutr Biochem. 2004;15:229-35.
27. Park HS, Chun CS, Kim S, Ha YL, Park JH. Dietary trans-10, cis-12 and cis-9,trans-11 conjugated linoleic acids induce apoptosis in the colonic mucosa of rats treated with 1,2-dimethylhydrazine. J Med Food. 2006;9:22-7.
28. Park HS, Ryu JH, Ha YL, Park JH. Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr. 2001;86:549-55.
29. Rajakangas J, Basu S, Salminen I, Mutanen M. Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-kappaB and cyclin D1 protein levels in the Min mouse. J Nutr. 2003;133:1943-8.
30. Rajakangas J, Turpeinen AM, Salminen I, Mutanen M. Effects of conjugated linoleic acid on adenoma formation in the ApcMin mouse. IARC Sci Publ. 2002;156:405-6.
31. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
32. Irizarry RA, Wu Z. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. proceeding of RECOMB, 2004. San Diego: RECOMB; 2004.
33. von Heydebreck A, Huber W, Gentleman RC. Differential expression of the Bioconductor Project. Bioconductor Project Working Papers 2004; Working Paper 7. Available from: http://www.bepress.com/bioconductor/paper7.
34. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:3.
35. Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for p-value adjustment. New York: John Wiley & Sons; 1993.
36. Affymetrix. http://www.affymetrix.com/index.affx. [cited 2007 Aug].
37. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2005;33:D54-8.
38. Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput. 2000;455-66.
39. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207-10.
40. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-9.
41. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70.
42. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545-50.
43. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365-86.
44. Snedecor GW, Cochran WG. Statistical methods. Ames (IA): Iowa State University Press; 1967.
45. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU, Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology. 2004;127:777-91.
46. Roche HM, Terres AM, Black IB, Gibney MJ, Kelleher D. Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells. Gut. 2001;48:797-802.
47. Lee SH, Yamaguchi K, Kim JS, Eling TE, Safe S, Park Y, Baek SJ. Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis. 2006;27:972-81.
48. Kemp MQ, Jeffy BD, Romagnolo DF. Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr. 2003;133:3670-7.
49. Yan C, Lu D, Hai T, Boyd DD. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 2005;24:2425-35.
50. Yan C, Jamaluddin MS, Aggarwal B, Myers J, Boyd DD. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther. 2005;4:233-41.
51. Fleet JC, Wood RJ. Identification of calbindin D-9k mRNA and its regulation by 1,25-dihydroxyvitamin D3 in Caco-2 cells. Arch Biochem Biophys. 1994;308:171-4.
52. Turksen K, Troy TC. Barriers built on claudins. J Cell Sci. 2004;117:2435-47.
53. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol. 1995;269:G467-75.
54. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol. 2004;36:1206-37.